Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a Human Immunodeficiency Virus type 1 chimeric virus

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8141-8148

  Shibata, Riri ^a   Siemon, Christine ^a   Czajak, Susan C ^b   Desrosiers, Ronald C ^b   Martin, Malcolm A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFECTION RESISTANCE; MACACA; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINE PRODUCTION; VIRUS ENVELOPE; VIRUS NEUTRALIZATION;

EID: 0030765973     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8141-8148.1997     Document Type: Article

References (61)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Ahmad, S., B. Lohman, M. Marthas, L. Giavedoni, Z. el-Amad, N. L. Haigwood, C. J. Scandella, M. B. Gardner, P. A. Luciw, and T. Yilma. 1994. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 10:195-204.
3. Almond, N., K. Kent, M. Cranage, E. Rud, B. Clarke, and E. J. Stott. 1995. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells. Lancet 345:1342-1344.
4. Arthur, L. O., J. Bess, Jr., D. J. Waters, S. W. Pyle, J. C. Kelliher, P. L. Nara, K. Krohn, W. G. Robey, A. J. Langlois, R. C. Gallo, and P. J. Fischinger. 1989. Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120. J. Virol. 63:5046-5053.
5. Berman, P. W., T. J. Gregory, L. Riddle, G. R. Nakamura, M. A. Champe, J. P. Porter, F. M. Wurm, R. D. Hershberg, E. K. Cobb, and J. W. Eichberg. 1990. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 345:622-625.
6. Bogers, W. M., H. Niphuis, P. ten Haaft, J. D. Laman, W. Koornstra, and J. L. Heeney. 1995. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge. AIDS 9:F13-F18.
7. Bruck, C., C. Thiriart, L. Fabry, M. Francotte, P. Pala, O. Van Opstal, J. Culp, M. Rosenberg, M. De Wilde, P. Heidt, and J. Heeney. 1994. HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees. Vaccine 12:1141-1148.
8. Clements, J. E., R. C. Montelaro, M. C. Zink, A. M. Amedee, S. Miller, A. M. Trichel, B. Jagerski, D. Hauer, L. N. Martin, R. P. Bohm, and M. Murphey-Corb. 1995. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus. J. Virol. 69:2737-2744.
9. Cranage, M. P., N. Polyanskaya, B. McBride, N. Cook, L. A. Ashworth, M. Dennis, A. Baskerville, P. J. Greenaway, T. Corcoran, P. Kitchin, J. Rose, M. Murphey-Corb, R. C. Desrosiers, E. J. Stott, and G. H. Farrar. 1993. Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 9:13-22.
10. Daniel, M. D., F. Kirchhoff, S. C. Czajak, P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258:1938-1941.
11. Daniel, M. D., G. P. Mazzara, M. A. Simon, P. K. Sehgal, T. Kodama, D. L. Panicali, and R. C. Desrosiers. 1994. High-liter immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection. AIDS Res. Hum. Retroviruses 10:839-851.
12. Desrosiers, R. C. 1992. HIV with multiple gene deletions as a live attenuated vaccine for AIDS. AIDS Res. Hum. Retroviruses 8:1457.
13. de Vries, P., J. L. Heeney, J. Boes, M. E. M. Dings, G. J. Hulskotte, R. Dubbes, W. Koornstra, P. ten Haaft, L. Akerblom, S. Eriksson, B. Morein, S. Norley, and D. M. E. Osterhaus. 1994. Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines. Vaccine 12:1443-1452.
14. Fenyo, E. M. 1994. Antigenic variation of primate lentiviruses in humans and experimentally infected macaques. Immunol. Rev. 140:131-146.
15. Franchini, G., M. Robert-Guroff, J. Tartaglia, A. Aggarwal, A. Abimiku, J. Benson, P. Markham, K. Limbach, G. Hurteau, J. Fullen, K. Aldrich, N. Miller, J. Sadoff, E. Paoletti, and R. C. Gallo. 1995. Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques. AIDS Res. Hum. Retroviruses 11:909-920.
16. Fultz, P. N., A. Srinivasan, C. R. Greene, D. Butler, R. B. Swenson, and H. M. McClure. 1987. Superinfection of a chimpanzee with a second strain of human immunodeficiency virus. J. Virol. 61:4026-4029.
17. Fultz, P. N., P. Nara, F. Barre-Sinoussi, A. Chaput, M. L. Greenberg, E. Muchmore, M. P. Kieny, and M. Girard. 1992. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science 256:1687-1690.
18. Galetto-Lacour, A., S. Yerly, T. V. Perneger, C. Baumberger, B. Hirschel, and L. Perrin. 1996. Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group. J. Infect. Dis. 173:1388-1393.
19. Giavedoni, L. D., V. Planelles, N. L. Haigwood, S. Ahmad, J. D. Kluge, M. L. Marthas, M. B. Gardner, P. A. Luciw, and T. D. Yilma. 1993. Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection. J. Virol. 67:577-583.
20. Gibbs, C., Jr., R. Peters, M. Gravell, B. K. Johnson, F. C. Jensen, D. J. Carlo, and J. Salk. 1991. Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees. Proc. Natl. Acad. Sci. USA 88:3348-3352.
21. Girard, M., M. P. Kieny, A. Pinter, F. Barre-Sinoussi, P. Nara, H. Kolbe, K. Kusumi, A. Chaput, T. Reinhart, E. Muchmore, J. Ronco, M. Kaczorek, E. Gomard, J.-C. Gluckman, and P. N. Fultz. 1991. Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 88:542-546.
22. Girard, M., B. Meignier, F. Barre-Sinoussi, M.-P. Kieny, T. Matthews, E. Muchmore, P. L. Nara, Q. Wei, L. Rimsky, K. Weinhold, and P. Fultz. 1995. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. J. Virol. 69:6239-6248.
23. Heeney, J. L., C. van Els, P. de Vries, P. ten Haaft, N. Otting, W. Koornstra, J. Boes, R. Dubbes, H. Niphuis, M. Dings, M. Cranage, S. Norley, M. Jonker, R. E. Bontrop, and A. Osterhaus. 1994. Major histocompatibility complex class I-associated vaccine protection from simian immunodeficiency virus-infected peripheral blood cells. J. Exp. Med. 180:769-774.
24. Hirsch, V. M., S. Goldstein, N. A. Hynes, W. R. Elkins, W. T. London, P. M. Zack, D. Montefiori, and P. R. Johnson. 1994. Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine. J. Infect. Dis. 170:51-59.
25. Hirsch, V. M., T. R. Fuerst, G. Sutter, M. W. Carroll, L. C. Yang, S. Goldstein, M. Piatak, Jr., W. R. Elkins, W. G. Alvord, D. C. Montefiori, B. Moss, and J. D. Lifson. 1996. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J. Virol. 70:3741-3752.
26. Hu, S. L., P. N. Fultz, H. M. McClure, J. W. Eichberg, E. K. Thomas, J. Zarling, M. C. Singhal, S. G. Kosowski, R. B. Swenson, D. C. Anderson, and G. Todaro. 1987. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection ot chimpanzees. Nature 328:721-723.
27. Hu, S. L., K. Abrams, G. N. Barber, P. Moran, J. M. Zarling, A. J. Langlois, L. Kuller, W. R. Morton, and R. E. Benveniste. 1992. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science 255:456-159.
28. Israel, Z. R., P. F. Edmonson, D. H. Maul, S. P. O'Neil, S. P. Mossman, C. Thiriart, L. Fabry, O. Van Opstal, C. Brack, F. Bex, A. Burny, P. N. Fultz, J. I. Mullins, and E. A. Hoover. 1994. Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. J. Virol. 68:1843-1853.
29. Lehner, T., Y. Wang, M. Cranage, L. A. Bergmeier, E. Mitchell, L. Tao, G. Hall, M. Dennis, N. Cook, R. Brookes, L. Klavinskis, I. Jones, C. Doyle, and R. Ward. 1996. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat. Med. 2:767-775.
30. Letvin, N. L., J. Li, M. Halloran, M. P. Cranage, E. W. Rud, and J. Sodroski. 1995. Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus. J. Virol. 69:4569-1571.
31. Lohman, B. L., M. B. McChesney, C. J. Miller, E. McGowan, S. M. Joye, K. K. Van Rompay, E. Reay, L. Antipa, N. C. Pedersen, and M. L. Marthas. 1994. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J. Virol. 68:7021-7029.
32. Marthas, M. L., S. Sutjipto, J. Higgins, B. Lohman, J. Torten, P. A. Luciw, P. A. Marx, and N. C. Pedersen. 1990. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J. Virol. 64:3694-3700.
33. Marthas, M. L., S. Sutjipto, C. J. Miller, J. Higgins, J. Torten, R. E. Unger, P. Marx, N. C. Pedersen, H. Kiyono, and J. R. McGhee. 1992. Efficacy of live-attenuated and whole-inactivated SIV vaccines against intraveneous and vaginal challenge, p. 117-122. In F. Brown, R. M. Chanock, H. S. Ginsberg, and R. A. Lerner (ed.), Vaccines 92. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
34. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
35. Miller, C. J., M. B. McChesney, X. Lu, P. J. Dailey, C. Chutkowski, D. Lu, P. Brosio, B. Roberts, and Y. Lu. 1997. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J. Virol. 71:1911-1921.
36. Mossman, S. P., F. Bex, P. Berglund, J. Arthos, S. P. O'Neil, D. Riley, D. H. Maul, C. Bruck, P. Momin, A. Burny, P. N. Fultz, J. I. Mullins, P. Liljestrom, and E. A. Hoover. 1996. Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J. Virol. 70:1953-1960.
37. mac. J. Virol. 62:4691-4696.
38. O'Brien, T. R., W. A. Blattner, D. Waters, E. Eyster, M. W. Hilgartner, A. R. Cohen, N. Luban, A. Hatzakis, L. M. Aledort, P. S. Rosenberg, W. J. Miley, B. L. Kroner, and J. J. Goedert. 1996. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 276:105-110.
39. Ohkawa, S., L. A. Wilson, G. Larosa, K. Javaherian, L. N. Martin, and M. Murphey-Corb. 1994. Immune responses induced by prototype vaccines for AIDS in rhesus monkeys. AIDS Res. Hum. Retroviruses 10:27-38.
40. Otsyula, M. G., C. J. Miller, A. F. Tarantal, M. L. Marthas, T. P. Greene, J. R. Collins, K. K. van Rompay, and M. B. McChesney. 1996. Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251. Virology 222:275-278.
41. Petry, H., U. Dittmer, C. Stahl-Hennig, C. Coulibaly, B. Makoschey, D. Fuchs, H. Wachter, T. Tolle, C. Morys-Wortmann, F. J. Kaup, E. Jurkiewicz, W. Luke, and G. Hunsmann. 1995. Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. J. Virol. 69:1564-1574.
42. Putkonen, P., E. Bjorling, L. Akerblom, R. Thorstensson, K. Lovgren, L. Benthin, F. Chiodi, B. Morein, G. Biberfeld, E. Norrby, and H. Wigzell. 1994. Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine. J. Acquired Immune Defic. Syndr. 7:551-559.
43. Putkonen, P., C. Nilsson, K. Hild, R. Benthin, M. Cranage, A. M. Aubertin, and G. Biberfeld. 1993. Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells. J. Med. Primatol. 22:100-103.
44. Putkonen, P., L. Walther, Y. J. Zhang, S. L. Li, C. Nilsson, J. Albert, P. Biberfeld, R. Thorstensson, and G. Biberfeld. 1995. Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nat. Med. 1:914-918.
45. Quesada-Rolander, M., B. Makitalo, R. Thorstensson, Y. J. Zhang, E. Castanos-Velez, G. Biberfeld, and P. Putkonen. 1996. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope AIDS Res. Hum. Retroviruses 12:993-999.
46. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-197.
47. Schlienger, K., D. C. Montefiori, M. Mancini, Y. Riviere, P. Tiollais, and M. L. Michel. 1994. Vaccine-induced neutralizing antibodies directed in part to the simian immunodeficiency virus (SIV) V2 domain were unable to protect rhesus monkeys from SIV experimental challenge. J. Virol. 68:6578-6588.
48. Shafferman, A., P. B. Jahrling, R. E. Benveniste, M. G. Lewis, T. J. Phipps, F. Eden-McCutchan, J. Sadoff, G. A. Eddy, and D. S. Burke. 1991. Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc. Natl. Acad. Sci. USA 88:7126-7130.
49. Shibata, R., M. D. Hoggan, C. Broscius, G. Englund, T. S. Theodore, A. Buckler-White, L. O. Arthur, Z. Israel, A. Schultz, H. C. Lane, and M. A. Martin. 1995. Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J. Virol. 69:4453-4462.
50. Shibata, R., M. Kawamura, H. Sakai, M. Hayami, A. Ishimoto, and A. Adachi. 1991. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65:3514-3520.
51. Shibata, R., F. Maldarelli, C. Siemon, T. Matano, M. Parta, G. Miller, T. Fredrickson, and M. A. Martin. 1997. Infection and pathogenicity of chimeric simian-human immunodeficiency viruses in macaques; determinants of high virus loads and CD4 cell killing. J. Infect. Dis. 176:362-373.
52. Shibata, R., C. Siemon, M. W. Cho, L. O. Arthur, S. Nigida, Jr., T. Matthews, L. A. Sawyer, A. Schultz, K. K. Murthy, Z. Israel, A. Javadian, P. Frost, R. C. Kennedy, H. C. Lane, and M. A. Martin. 1996. Resistance of previously infected chimpanzees to successive challenges with a heterologous intraclade B strain of human immunodeficiency virus type 1. J. Virol. 70:4361-4369.
53. Siegel, F., R. Kurth, and S. Norley. 1995. Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protects against SIVagm infection in the African green monkey natural host. J. Acquired Immune Defic. Syndr. Hum. Retroviruses 8:217-226.
54. Stahl-Hennig, C., C. Coulibaly, H. Petry, G. Voss, U. Dittmer, W. Bodemer, B. Makoschey, E. Jurkiewicz, W. Luke, and G. Hunsmann. 1994. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo. AIDS Res. Hum. Retroviruses 10:S27-S32.
55. Stahl-Hennig, C., U. Dittmer, T. Nisslein, H. Petry, E. Jurkiewicz, D. Fuchs, H. Wachter, K. Matz-Rensing, E. M. Kuhn, F. J. Kaup, E. W. Rud, and G. Hunsmann. 1996. Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J. Gen. Virol. 77:2969-2981.
56. Theodore, T. S., C. Siemon, A. Buckler-White, R. Shibata, and M. A. Martin. Unpublished data.
57. Titti, F., M. L. Koanga Mogtomo, A. Borsetti, A. Geraci, L. Sernicola, G. Panzini, G. P. Turillazzi, S. Baroncelli, A. Giovannetti, R. Zamarchi, A. Amadori, F. Dianzani, L. Chieco-Bianchi, G. B. Rossi, and P. Verani. 1993. Immunization of Macaca fascicularis with inactivated SIV preparations: challenge with human-or monkey-derived SIV and the effects of a longer immunization schedule. J. Med. Primatol. 22:110-118.
58. Van Rompay, K. K., M. G. Otsyula, R. P. Tarara, D. R. Canfield, C. J. Berardi, M. B. McChesney, and M. L. Marthas. 1996. Vaccination of pregnant macaques protects newborns against mucosal simian immunodeficiency virus infection. J. Infect. Dis. 173:1327-1335.
59. Wakrim, L., R. Le Grand, B. Vaslin, A. Cheret, F. Matheux, F. Theodoro, P. Roques, I. Nicol-Jourdain, and D. Dormont. 1996. Superinfection of HIV-2-preinfected macaques after rectal exposure to a primary isolate of SIVmac251. Virology 221:260-270.
60. Willey, R. L., D. H. Smith, L. A. Lasky, T. S. Theodore, P. L. Earl, B. Moss, D. J. Capon, and M. A. Martin. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62:139-147.
61. Wyand, M. S., K. H. Manson, M. Garcia-Moll, D. Montefiori, and R. C. Desrosiers. 1996. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. 70:3724-3733.